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Abstract To study the substrate speciﬁcity of enzymes, we
use the amidohydrolase and enolase superfamilies as model
systems; members of these superfamilies share a common
TIM barrel fold and catalyze a wide range of chemical reac-
tions. Here, we describe a collaboration between the Enzyme
Speciﬁcity Consortium (ENSPEC) and the New York SGX
Research Center for Structural Genomics (NYSGXRC) that
aims to maximize the structural coverage of the amidohy-
drolase and enolase superfamilies. Using sequence- and
structure-based protein comparisons, we ﬁrst selected 535
targetproteinsfromavarietyofgenomesforhigh-throughput
structure determination by X-ray crystallography; 63 of these
targets were not previously annotated as superfamily mem-
bers. To date, 20 unique amidohydrolase and 41 unique
enolase structures have been determined, increasing the
fraction of sequences in the two superfamilies that can be
modeledbasedonatleast30%sequenceidentityfrom45%to
73%. We present case studies of proteins related to uronate
isomerase (an amidohydrolase superfamily member) and
mandelate racemase (an enolase superfamily member), to
illustrate how this structure-focused approach can be used to
generate hypotheses about sequence–structure–function
relationships.
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Introduction
A long-standing challenge in biology is to predict the
molecular function of proteins from their sequences and/or
structures. This task is facilitated by a limited number of
domain folds [1], restricting the set of structural types that
must be studied in deducing a much larger set of functions.
Special challenges, however, exist for functional prediction
in different classes of proteins. For example, the function
of an enzyme often cannot be correctly predicted because
there are no clear links from the domain fold to the cata-
lytic function and substrate speciﬁcity. Off-setting these
problems, studies of genomes and sets of homologous
proteins demonstrate that some aspects of catalysis are
often conserved between evolutionarily-related proteins,
even when these proteins catalyze different overall reac-
tions [2–4]. This empirical observation restricts the
functional space that must be considered, further
facilitating prediction and leading to deﬁnitions of
homologous sets of enzymes in terms of protein super-
families and families based not only on structural
conservation, but also on functional conservation [5]:
Superfamily members share a common ancestor and
potentially some aspects of function, while members of the
same family are isofunctional, catalyzing the same overall
reaction(s).
The large and diverse amidohydrolase and enolase
superfamilies provide a particularly attractive opportunity
to study the problem of predicting substrate speciﬁcity and
enzymatic mechanisms from evolutionary and physical
perspectives. These superfamilies are attractive targets
because signiﬁcant knowledge about the speciﬁcity of
many of their members already exists, while there are still
large areas of their sequence space where we do not have
any structural or functional information.
Members of the amidohydrolase superfamily catalyze
the hydrolysis of a wide range of substrates bearing amide
or ester functional groups at carbon and phosphorus centers
[6, 7]. A common feature for this superfamily is a mono-
nuclear or binuclear metal center coordinated in a
(b/a)8-barrel (TIM barrel) polypeptide chain fold. The
active site is formed by loops at the C-terminal ends of the
b-strands. Currently, 36 named families have been identi-
ﬁed based on the experimentally veriﬁed catalytic
reactions. The set of superfamily sequences has been
clustered into 90 subgroups based on sequence and in some
cases active site similarities (the Structure-Function Link-
age Database [8]: http://sﬂd.rbvi.ucsf.edu). In some
subgroups, additional information about chemical reactions
catalyzed by subgroup members is available; for many of
the subgroups, however, no information about functional
speciﬁcity is available.
Enolase superfamily members catalyze the abstraction
of a proton a to a carboxylic acid to form an enolate anion
intermediate [9, 10]. Members of this superfamily share an
N-terminal a?b capping domain, as well as a C-terminal
(b/a)7b-barrel domain (modiﬁed TIM barrel). The active
site is formed by loops at the C-terminal ends of the TIM
barrel b-strands and two ﬂexible loops from the capping
domain; the active site also includes a Mg
2? ion [11].
Reactions catalyzed by enolases are less diverse than those
of the amidohydrolases. The enolases are currently orga-
nized into 16 named families and 6 subgroups [8].
Approximately 50% of the sequences in the superfamily
are of unknown function.
The amidohydrolase and enolase superfamilies are the
focus of our Enzyme Speciﬁcity Consortium (ENSPEC),
members of which include protein crystallographers,
enzymologists, and computational biologists. We aim to
predict the substrate speciﬁcity of an enzyme based on its
experimentally determined and/or modeled structure
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123[2–4, 7, 10–42]. This goal has been enabled by determi-
nation of crystallographic structures representing many of
the amidohydrolase and enolase families.
To maximize the number of experimentally determined
structures,ENSPEChascollaboratedwiththeNewYorkSGX
Research Center for Structural Genomics (NYSGXRC),
which is one of the four large-scale production centers of the
Protein Structure Initiative (PSI) (http://www.nigms.nih.gov/
Initiatives/PSI;[43]).NIHguidelinesmandatethat70%ofthe
PSItargetscomefromdiverseproteinfamiliesselectedbyand
sharedamongthefourproductioncenters[43].About15%of
the targets are reserved for proteins of biomedical relevance
deﬁned by each center, and the remaining 15% are ‘‘com-
munity-nominated’’ targets. Several hundred of the
NYSGXRC community targets are amidohydrolases and
enolases nominated by ENSPEC. To date, the collaboration
has determined 25 amidohydrolaseand 50enolase structures,
contributing substantially to the total of 154 amidohydrolase
and 89 enolase structures in the Protein Data Bank (PDB;
6/16/08) [44].
We begin by outlining the data sources and methods
used for target selection and structure-based functional
annotation (Materials and Methods). Second, we present
the results of the target selection process, the status of the
selected targets in the structural genomics pipeline, and the
improvement in the modeling of the amidohydrolase and
enolase superfamilies made possible by the new crystal-
lographic structures (Results and Discussion). We conclude
by discussing the biological impact of two sample target
structures.
Materials and methods
Target selection
Target selection begins by identifying sequences of known
members of the superfamilies (seed sequences), followed
by ﬁltering to obtain an initial target list. To identify
additional members, we applied sequence- and structure-
based expansion methods, followed by ﬁltering for source
organisms preferred by NYSGXRC. Superfamily mem-
bership for the additional targets was veriﬁed by expert
curators by inspecting their sequences for probable cata-
lytic residues. A web-based target selection tool was also
constructed for further manual ﬁltering to obtain the ﬁnal
target list.
Seed sequence sources
Veriﬁed amidohydrolase and enolase superfamily sequences
(i.e., seed sequences) were obtained from the Structure Func-
tion Linkage Database (SFLD; http://sﬂd.rbvi.ucsf.edu/)[ 8].
The SFLD database is a manually constructed database that
classiﬁes enzymes hierarchically, based on speciﬁc
sequence, structure, and functional criteria. The database is
updated by a semi-automated method that detects new
superfamily members by matching their sequences to
Hidden Markov Models trained using the sequences of
veriﬁed superfamily members, with subsequent manual
inspection to verify the presence of catalytic residues. In
June 2005, when our target list was constructed, the SFLD
contained 3,701 amidohydrolases and 1,795 enolases.
1
Filtering of seed sequences
PSI guidelines require that structural genomics targets share
*30%orlessaminoacidsequenceidentitytoaknownthee-
dimensional structure. To satisfy this condition, the seed
amidohydrolase and enolase sequences were processed
using the automated comparative modeling server
MODWEB (http://salilab.org/modweb)[ 45]. Sequences
with morethan 30%sequenceidentity toanystructureinthe
PDB over at least 70% of their length were identiﬁed and
excluded from further consideration.
Sequence-based expansion of amidohydrolase and enolase
superfamily members
For each seed amidohydrolase and enolase, homologous
sequences in the UNIPROT database [46] were identiﬁed
by the BUILD_PROFILE routine of MODELLER-9 [45].
BUILD_PROFILE is an iterative database-searching tool
that relies on local dynamic programming to generate
alignments and a robust estimate of their statistical sig-
niﬁcance. This method identiﬁed additional potential
amidohydrolase and enolase sequences that were not
present in the seed sequence pools.
Structure-based expansion of amidohydrolase superfamily
members
In addition to the SFLD entries, we also used the known
amidohydrolase superfamily structures to ﬁnd additional
potential amidohydrolase superfamily members (this
expansion was not performed for the enolase superfamily).
We began by splitting 100 PDB ﬁles containing known
amidohydrolase structures (June 2005) into separate
monomeric structures and clustering them at 80% sequence
identity. The resulting 45 non-redundant structures were
1 The numbers of sequences in the publicly accessible version of the
SFLD differ from those cited here because large numbers of
sequences are undergoing curation at any given time and are therefore
not yet listed on the public site.
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eling server MODWEB [45].
First, each structure sequence was used as a query to ﬁnd
its homologs in UNIPROT using PSIBLAST [47]. Second,
these homologs were modeled using the corresponding
structure as a template. All models were deposited in our
comprehensiveMODBASEdatabaseofcomparativeprotein
structure models (http://salilab.org/modbase/; direct links to
thedatasetscanbefoundinthesupplementalmaterials)[48].
In addition, the amidohydrolase homologs found in UNIPROT
were ﬁltered by removing known amidohydrolase super-
familymembers,andthensubjectedtostandardcomparative
modelingwith MODWEBusingall non-redundant chainsin
the PDB as potential templates. This step allowed us to
eliminate sequences that are likely members of other
superfamilies, judged by sequence identity and coverage.
Filtering by organism
While seed sequences could come from any genome, the
additional amidohydrolase sequences identiﬁed by
sequence- and structure-based expansions were ﬁltered for
ease of cloning to include only 79 organisms with genomic
DNA available to NYSGXRC in 2005 and the marine
metagenome from the Sargasso Sea sequencing project
(formerly called environmental sequences) [49]. For sim-
plicity, we callthe 79 genomes plus the marine metagenome
the ‘‘NYSGXRC genomes’’ (Table 1). The NYSGXRC
reagent genomes have since been expanded to include over
115 organisms.
Veriﬁcation of catalytic residues
The putative amidohydrolase sequences resulting from the
sequence- and structure-based expansions were aligned to
existing amidohydrolase Hidden Markov Models (HMMs)
in the SFLD and manually inspected for probable catalytic
residues. The ﬁnal target list only includes sequences with
at least 70% of the catalytic residues present.
Target selection tool
For ﬁnal manual ﬁltering of the target list, we constructed a
web-based target selection tool. The tool comprises a
combination of MySQL database tables with an interactive
web-interface using LAMP [50]. It contains information
about the sequences, including UNIPROT annotation,
organism, sequence length, closest known structure,
sequence identity to other cluster members, and domain
boundaries for the TIM barrel domain obtained from
SFLD. The interface allows searching for project datasets,
organism groups, homologs based on sequence identity,
and clusters of related sequences; the resulting sequences
can be ﬂagged for rejection or inclusion into the ﬁnal target
list.
Analysis of the target structures
The amidohydrolase and enolase superfamilies were
annotated using computational tools. Cytoscape clustering
gives an overview of how the targets are distributed across
the superfamily [51]. Also, template-based modeling
determines how many new sequences can be modeled with
the new structural information [45].
Sequence clustering of amidohydrolase superfamily by
cytoscape
The time required to perfom BLAST searches against the
NCBI non-redundant database (NR) of protein sequences
[52] was prohibitive due to the size and complexity of the
superfamily. Thus, a custom database was created con-
taining only the amidohydrolase sequences in the SFLD.
To generate the all-by-all connections for cytoscape clus-
tering, BLAST searches were then performed against this
database at an E-value cutoff of 10
-10, using each
sequence in the set as a query. Because this custom data-
base contained only sequences known to be members of the
amidohydrolase superfamily, the generation of E-values is
biased. Consequently, the E-values from this analysis
cannot be directly compared to those calculated by BLAST
against the NCBI NR database. A cytoscape [51] network
was created from these BLAST results. In the absence of
established statistical techniques for selecting the E-value
cutoff, we examined the superfamily networks at a number
of different E-value cutoffs, and present here only one of
the corresponding networks, at an E-value cutoff of 10
-10.
Further discussion regarding choosing and interpreting E-
value cutoffs for sequence similarity networks may be
found in [53]. Each node in the network represents a single
sequence and each edge represents the pairwise connection
between two sequences with the most signiﬁcant BLAST
E-value (better than the cut-off) connecting the two
sequences. Lengths of edges are not meaningful, except
that sequences in tightly clustered groups are more similar
to each other than sequences with few connections. The
nodes were arranged using the yFiles organic layout pro-
vided in Cytoscape version 2.4. Tools for visualization of
protein networks were created by the UCSF Resource for
Biocomputing, Visualization, and Informatics (http://
www.rbvi.ucsf.edu).
Sequence clustering of enolase superfamily by cytoscape
To generate the all-by-all connections for cytoscape clus-
tering, BLAST analysis was performed against the NR
110 U. Pieper et al.
123database, using the sequences in the mandelate racemase-
like, glucarate dehydratase-like, mannonate dehydratase-
like, and muconate cycloisomerase-like subgroups of the
SFLD enolase superfamily. The enolase subgroup was not
included in this analysis. Almost all of the enolase sub-
group members are in the enolase family, the sequences of
which are all isofunctional, i.e. they all perform the well-
characterized enolase reaction, important in glycolysis.
Only hits in the aforementioned subgroups were used for
further analysis. The cytoscape network was created as
described above, but using an E-value cutoff for this
superfamily of 10
-40.
Table 1 List of 80 NYSGXRC genomes (as of June 2005)
Organism Taxonomy ID Organism Taxonomy ID
Aeropyrum pernix 56636 Listeria monocytogenes 1639
Aquifex aeolicus 63363 Metagenome sequences (Gene synthesis) 256318
Arabidopsis thaliana 3702 Methanococcus jannaschi 2190
Archaeoglobus fulgidus 2234 Mus musculus 10090
Bacillus cereus 1396 Mycobacterium turberculosis H37Rv 83332
Bacillus halodurnas 86665 Mycoplasma pneumonia 2104
Bacillus subtilis 1423 Neisseria gonorrhoeae 485
Bacillus thuringiensis 1428 Neisseria meningitidis 487
Bartonella henselae 38323 Nostoc 1180
Bordetella pertussis 520 Oryctolagus cuniculus 9986
Borrelia burgdorferi 139 Oryza sativa 4530
Bos taurus 9913 Ovis aries 9940
Caenorhabditis elegans 6239 Porphyromonas gingivalis 837
Campylobacter jejuni 197 Pseudomonas aeruginosa 287
Candida albicans 5476 Pseudomonas putida 303
Canis familiaris 9615 Pyrococcus furiosus 2261
Capra hircus 9925 Pyrococcus horikoshii 53953
Caulobacter vibrioides 155892 Rattus norvegicus 10116
Clostridium acetobutylicum 1488 Rhodobacter sphaeroides 1063
Corynebacterium diphtheriae 1717 Saccharomyces cerevisiae 4932
Cryptococcus neoformans 5207 Salmonella typhimurium 602
Cryptosporidium parvum 5807 Schizosaccharomyces pombe 4896
Deinococcus radiodurans 1299 Shigella Flexneri type 2a 42897
Desulfovibrio vulgaris 881 Simian immunodeﬁciency virus 11723
Dictyostelium discoideum 44689 Staphylococcus aureus 1280
Drosophila melanogaster 7227 Staphylococcus epidermidis 1282
Enterobacter cloacae 550 Streptococcus mutans 1309
Enterococcus faecalis 1351 Streptococcus pneumoniae 1313
Equus caballus 9796 Streptococcus pyogenes 1314
Escherichia coli 562 Sulfolobus solfataricus 2287
Escherichia coli 0157:H7 83334 Sus scrofa 9823
Felis catus 9685 Takifugu rubripes 31033
Gallus gallus 9031 Thermoplasma acidophilum 2303
Haemophilus inﬂuenzae 727 Thermoplasma volcanium 50339
Halobacterium sp. NRC-1 64091 Thermotoga maritima 2336
Helicobacter pylori 210 Ureaplasma urealyticum 2130
Homo sapiens 9606 Vibrio cholerae 666
Human immunodeﬁciency virus type 1 11676 Xenopus laevis 8355
Klebsiella pneumoniae 573 Xylella fastidiosa 2371
Legionella pneumophila 446 Zea mays 4577
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123Template-based modeling by MODWEB
Automated comparative modeling of all known protein
sequences using the new NYSGXRC crystallographic
structures as templates was performed with MODWEB
[45]. We relied on the MODWEB option that allows using
a protein structure as input and results in models for all of
the identiﬁable sequence homologs of the input structure
fromtheNCBINRdatabase;thesehomologswereidentiﬁed
during ten PSI-BLAST iterations of the template sequence
against NR (E-value cutoff is 0.0001). The results are
available at http://salilab.org/modbase/models_nysgxrc_
latest.html (Table 2).
Results and discussion
We ﬁrst present the results of the target selection procedure.
We also describe the current snapshot of the progress of the
targets through our structural genomics pipeline (June
2008). We then indicate how the resulting crystallographic
structuresaredistributed acrossthe twosuperfamilies. Next,
we determine the number of protein sequences in the
comprehensive sequence databases that are detectably
related to these protein structures (i.e., the modeling lever-
age). Finally, for each of the two superfamilies, we describe
an example target with interesting biological features.
Target selection
Given the capacities of ENSPEC and NYSGXRC, the goal
was to identify approximately 500 target sequences,
approximately evenly distributed between the two super-
families. These targets were obtained by selecting
representatives from previously identiﬁed superfamily
members as well as by identifying new superfamily mem-
bers in a select set of genomes (Materials and Methods).
Targets for the amidohydrolase superfamily
From the SFLD, we obtained a list of 3,701 amidohydro-
lase superfamily members. The ﬁrst ﬁltering step resulted
in 1,918 sequences with less than 30% sequence identity to
a known structure and at least 250 amino acid residues in
length, originating from 424 organisms. We chose the 30%
sequence identity limit, in congruence with NIH PSI
guidelines, to concentrate our efforts on protein sequences
with limited structural knowledge; sequences related at less
than 30% sequence identity to the closest known structure
are frequently modeled inaccurately due to errors in the
corresponding target-template alignments [54–56].
These 1,918 sequences were further ﬁltered manually
using the target selection tool to obtain the reduced set of
224 target sequences. The selected amidohydrolase super-
family members are evenly distributed among the various
clades of the superfamily, thus representing the diversity
within the superfamily. Preference was given to the NY-
SGXRC genomes, but other organisms were also
considered.
The 224 targets can be divided into 76 clusters with less
than 30% sequence identity between any pair of sequences
from two different clusters, 126 clusters at 50% sequence
identity, and 177 clusters at 80% sequence identity. The
amidohydrolase superfamily members all contain the
deﬁning conserved TIM barrel domain with some variation
in their lengths; all targets are between 224 and 628 amino
acid residues long, with 90% of them shorter than 500 resi-
dues. The length variation stems mostly from loops that
connect the main secondary structure elements of the TIM
barrel fold and is consistent with the previously observed
sizerangeforTIMbarreldomains(150to500residues[57]).
In addition to the known superfamily members, the
sequence- and structure-based expansions detected 63
putative amidohydrolase superfamily members that were
not initially in the SFLD (Table 3). These new potential
targets fall into two categories: (i) divergent sequences that
were detected by the sequence-based approach (Fig. 1,
blue box) and (ii) divergent sequences that were detected
by the structure-based approach (Fig. 1, orange box). Of
the 63 putative amidohydrolase superfamily sequences, 50
were subsequently veriﬁed using the SFLD update proce-
dure. The presence of probable catalytic residues for the
remaining 13 targets was veriﬁed manually. Nine of these
13 sequences were detected by both the sequence- and
structure-based approaches, and four sequences were only
detected by the structure-based approach. Thus, the
sequence- and structure-based approaches yielded 13
additional targets that could not be identiﬁed as amidohy-
drolase superfamily members using previously available
protocols (corresponding to 21% of the new putative
members of the amidohydrolase superfamily).
In summary, the ﬁnal amidohydrolase target list
includes 224 previously identiﬁed amidohydrolase super-
family members, as well as the 63 newly identiﬁed
sequences. The ﬁnal list includes 287 sequences from 53
organisms that cover 22 (61%) of the named families in the
superfamily (Fig. 2).
Targets for the enolase superfamily
We used a simpler selection scheme for the enolase
superfamily members, because previous detailed studies
have effectively found all of the superfamily members in
publicly available sequence and structure databases (data
not shown). Of the 1,795 sequences already established as
enolase superfamily members, we selected as targets the
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123Table 3 Putative amidohydrolase superfamily members
Database ID
(GenPept
GI IDs)
Method Organism Length Annotation available at target selection Veriﬁcation
7462218 Structure-based Thermotoga maritima 434 Conserved hypothetical protein HMM
7497374 Structure-based Caenorhabditis elegans 818 Hypothetical protein C44B7.10 HMM
7500805 Structure-based Caenorhabditis elegans 313 T21966 hypothetical protein
F38E11.3—Caenorhabditis elegans
HMM
9948434 Structure-based Pseudomonas aeruginosa
PAO1
448 Probable dipeptidase precursor (Pseudomonas
aeruginosa)
HMM
10173106 Structure-based Bacillus halodurans 427 BH0493 HMM
10175729 Structure-based Bacillus halodurans 571 DNA-dependent DNA polymerase beta chain HMM
13700943 Structure-based Staphylococcus aureus
subsp. aureus N315
570 DNA-dependent DNA polymerase beta chain HMM
14600641 Structure-based Aeropyrum pernix 313 313aa long hypothetical microsomal dipeptidase HMM
14601853 Template Aeropyrum pernix 394 Hypothetical protein (Aeropyrum pernix) HMM
14602106 Structure-based Aeropyrum pernix 327 Hypothetical protein (Aeropyrum pernix) HMM
15600589 Structure-based Pseudomonas aeruginosa
PAO1
325 D82971 hypothetical protein PA5396
(imported)—Pseudomonas aeruginosa (strain
PAO1)
HMM
15612748 Structure-based Bacillus halodurans 448 BH0185 HMM
15614834 Structure-based Bacillus halodurans 310 Dipeptidase HMM
15791917 Structure-based Campylobacter jejuni
subsp. jejuni NCTC
265 Hypothetical protein Cj0556 HMM
15805850 Structure-based Deinococcus radiodurans
R1
418 Hydrolase, putative HMM
15896580 Structure-based Clostridium acetobutylicum 262 Predicted amidohydrolase (dihydroorotase family) HMM
15898656 Structure-based Sulfolobus solfataricus 314 Microsomal dipeptidase HMM
15925570 Structure-based Staphylococcus aureus
subsp. aureus N315
336 Conserved hypothetical protein HMM
16125737 Structure-based Caulobacter vibrioides 487 Uronate isomerase (EC 5.3.1.12) (Glucuronate
isomerase) (UronicDE isomerase)
HMM
16126978 Structure-based Caulobacter vibrioides 417 Dipeptidase HMM
16127409 Structure-based Caulobacter vibrioides 353 Hypothetical protein HMM
16130781 Structure-based Escherichia coli K12 464 Soluble protein involved in cell viability at the
beginning of stationary phase; soluble protein
involved in cell viability at the beginning of
stationary phase, contains urease domain
HMM
16410647 Structure-based Listeria monocytogenes
EGD-e
570 lmo1231 HMM
17556402 Structure-based Caenorhabditis elegans 352 Hypothetical protein Y71D11A.3a HMM
19705473 Structure-based Rattus norvegicus 336 2-amino-3-carboxymuconate-6-semialdehyde
decarboxylase
HMM
19911227 Structure-based Homo sapiens 336 2-amino-3-carboxylmuconate-6-semialdehyde
decarboxylase
HMM
19911231 Structure-based Caenorhabditis elegans 401 2-amino-3-carboxylmuconate-6-semialdehyde
decarboxylase
HMM
24379660 Structure-based Streptococcus mutans
UA159
267 conserved hypothetical protein HMM
33592291 Structure-based Bordetella pertussis
Tohama I
284 Putative 2-pyrone-4,6-dicarboxylic acid
hydrolase
HMM
33593502 Structure-based Bordetella pertussis
Tohama I
341 Putative dipeptidase HMM
39976001 Sequence- and
structure-based
Magnaporthe grisea 70–15 417 Hypothetical protein HMM
Target selection and annotation for the structural genomics of the amidohydrolase and enolase superfamilies 115
123Table 3 continued
Database ID
(GenPept
GI IDs)
Method Organism Length Annotation available at target selection Veriﬁcation
42527610 Structure-based Treponema denticola
ATCC 35405
371 Dihydroorotase, putative HMM
42631159 Structure-based Haemophilus inﬂuenzae 330 Hypothetical protein HMM
51012913 Structure-based Saccharomyces cerevisiae 313 YMR262W HMM
51968376 Structure-based Arabidopsis thaliana 346 Unnamed protein product HMM
51968996 Structure-based Arabidopsis thaliana 346 Unnamed protein product HMM
55980841 Structure-based Thermus thermophilus HB8 369 Amidohydrolase family protein HMM
60279993 STRUCTURE-based Pseudomonas aeruginosa 403 PvdM HMM
66807941 Structure-based Dictyostelium discoideum 359 Hypothetical protein HMM
66808659 Structure-based Dictyostelium discoideum 322 Hypothetical protein HMM
1065989 Sequence-based Bacillus subtilis subsp.
subtilis str. 1
577 Adenine deaminase HMM
15023784 Sequence-based Clostridium acetobutylicum 570 Adenine deaminase HMM
24636152 Structure-based Caenorhabditis elegans 403 Hypothetical protein C44B7.12 HMM
29377069 Structure-based Enterococcus faecalis V583 444 Chlorohydrolase family protein HMM
40788915 Structure-based Homo sapiens 777 Q93075_chr3:10265710-
10295706_H233R_V272I_L374P PUTATIVE
DEOXYRIBONUCLEASE KIAA0218
(EC 3.1.21.-)
HMM
45446932 Sequence- and
structure-based
Drosophila melanogaster 774 CG32626-PA, isoform A HMM
56203368 Sequence- and
structure-based
Homo sapiens 776 Adenosine monophosphate deaminase 1
(isoform M
HMM
56203369 Sequence-based Homo sapiens 780 OTTHUMP00000059283 HMM
57230710 Structure-based Filobasidiella neoformans 469 Hydrolase, putative HMM
63055053 Structure-based Homo sapiens 761 TatD DNase domain containing 2 HMM
68250266 Structure-based Haemophilus inﬂuenzae 251 Conserved putative deoxyribonuclease HMM
429129 Sequence-based Saccharomyces cerevisiae 797 YB9Z_YEAST HYPOTHETICAL 92.9 KD
PROTEIN IN SSH1-APE3 INTERGENIC
REGION
Manual
7293948 Sequence-based Drosophila melanogaster 520 CG5998-PA Manual
11463854 Sequence-based Drosophila melanogaster 561 Male-speciﬁc IDGF manual
14602062 Structure-based Aeropyrum pernix 375 Hypothetical protein [Aeropyrum pernix] Manual
15898896 Structure-based Sulfolobus solfataricus 269 Conserved hypothetical protein Manual
16264026 Template Sinorhizobium meliloti 466 HYPOTHETICAL PROTEIN Manual
17646150 Sequence- and
structure-based
Drosophila melanogaster 506 Adenosine deaminase-related growth factor C Manual
23093239 Sequence-based Drosophila melanogaster 561 CG32178-PA Manual
25009707 Sequence-based Drosophila melanogaster 561 AT05468p Manual
33593596 Structure-based Bordetella pertussis
Tohama I
523 Conserved hypothetical protein Manual
40744823 Structure-based Aspergillus nidulans FGSC
A4
562 HYPOTHETICAL protein Manual
47678365 Sequence-based Homo sapiens 511 Cat eye syndrome critical region
protein 1 [Homo sapiens]
Manual
49116836 Sequence- and
structure-based
Xenopus laevis 510 Hypothetical protein Manual
Tables listing all amidohydrolase and enolase superfamily targets can be found at http://salilab.org/projects/enspec/ (HMM Hidden Markov
Model veriﬁcation)
116 U. Pieper et al.
123255 sequences with less than 30% sequence identity to a
known structure over at least 250 residues in length, orig-
inating from 98 organisms. These targets form 74 clusters
at the 30% sequence identity cutoff, 126 clusters at 50%
sequence identity, and 196 clusters at 80% sequence
identity. The length distribution is 200 to 656 amino acid
residues, with 90% of the sequences between 200 and 405
residues in length.
A complete list of the selected amidohydrolase and
enolase superfamily targets can be found at http://salilab.
org/projects/enspec/.
Structural genomics pipeline attrition
To date, 254 amidohydrolase (88%) and 206 enolase (80%)
superfamily members have been attempted using the
NYSGXRC/ENSPEC X-ray crystallographic structure
determination pipeline. Progress to date and attrition rate at
each stage of the pipeline are documented in Table 4 (June
2008). The project has not yet been completed, and a
number of targets are still progressing through the pipeline.
Also, a few targets in the target list have not yet been
entered in the experimental pipeline. Therefore, the ﬁnal
overall success rate should be higher than that presented in
Table 4. Experimental results for all NYSGXRC Com-
munity-nominated targets are updated weekly in PepcDB
(http://pepcdb.pdb.org/).
Clear trends are observed in the success rates of crys-
tallization and subsequent crystallographic structure
determination for the amidohydrolase and enolase super-
family members. While only 38% of the puriﬁed targets
were members of the enolase superfamily, they comprise
67% of the unique experimental structures. If crystals are
obtained for an enolase superfamily member, there is a
good chance that its structure will be successfully deter-
mined. On the other hand, for at least a quarter of the
amidohydrolase proteins, we observed unusually broad
peaks in the electrospray ionization (ESI) mass spectra of
the intact proteins, indicative of heterogeneity in the
preparation. Proteolytic digestion followed by tandem mass
spectrometry analysis was carried out on the heterogeneous
proteins; multiple sites of oxidation and methylation were
identiﬁed with 90% of the protein sequence typically
identiﬁed. These modiﬁcations were the source of the
sample heterogeneity, and thus one reason for the limited
success in obtaining usable crystallographic datasets from
crystals of these amidohydrolases.
Of structural and functional interest was the fact that the
oxidation sites were primarily located at histidine residues
adjacent to Fe
2? ions in the presumed active sites of the
amidohydrolases. Excess oxidation can be avoided using
an alternate expression system (e.g. baculovirus) or adding
excess Mn
2? and an iron chelator such as 2,20-dipyridyl
prior to induction during E. coli expression. In contrast,
oxidation was not been observed in members of the enolase
superfamily, since these proteins bind only a divalent metal
ion such as Mg
2? or Mn
2? and not iron.
Analysis of the resulting crystallographic structures
Leverage of new crystallographic structures by modeling
To determine the impact of a structure on the structural
mapping of the protein sequence space, we determine how
many known protein sequences can be modeled based on
the structure (i.e., the modeling leverage) (Table 2). Each
enolase structure is a useful template for calculating
comparative models for 2,500 to 3,200 other protein
sequences in the NR database; a template is considered
useful when the resulting model is based on a signiﬁcant
PSI-BLAST E-value (0.0001) or a favorable GA341 model
score ([0.7). In contrast, the amidohydrolase superfamily
structures fall into two categories: most are detectably
related to 3,000–3,800 other proteins, but ﬁve structures
(PDB Codes: 2I5G, 2Q01, 2Q6E, 2RAG, and 3B40) are
related to a signiﬁcantly smaller number of sequences
(approximately 300–1,000).
Fig. 1 Flowchart of the target expansion strategy of sequence-based
target expansion (left) and structure-based target expansion (right)
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modeling results for all NYSGXRC structures as of May
2007 (Table 5) shows that the average number of models
per structure is signiﬁcantly higher for the amidohydrolase
and enolase superfamilies than for all structures determined
by NYSGXRC (2,681 vs. 1,964). This difference reﬂects
the relatively large sizes of the amidohydrolase and enolase
superfamilies; according to the Superfamily database
(http://supfam.org,[ 58]), across all of the superfamilies in
the database, there are on average 1,770 protein sequences
per superfamily.
Breaking down the modeling leverage by sequence
identity reveals that the modeling leverage for the amido-
hydrolase and enolase superfamily structures is higher and
lower than that for all NYSGXRC structures below and
above the sequence identity cutoff of 30%, respectively.
These differences are likely due in part to the relatively
high diversity in the amidohydrolase and enolase
superfamilies.
Upon initiation of the ENSPEC/NYSGXRC effort in
June 2005, 45% of all known members of the amidohy-
drolase and enolase superfamilies were related to a known
structure with a sequence identity higher than 30%. Due to
the increased number of templates from the amidohydro-
lase and enolase superfamilies contributed by our
consortia, this number increased to from 45% to 73%.
The total number of unique sequences modeled using
the new amidohydrolase and enolase superfamily structures
is 11,097, approximately 30% more than the number of
known sequences from the amidohydrolase and enolase
superfamilies. Among these additional sequences, we
expect both members of other superfamilies with the TIM
Fig. 2 Phylogenetic tree of the
organisms for the selected
amidohydrolase targets. The
numbers in parentheses
represent the number of targets
for conﬁrmed (ﬁrst number) and
putative (second number)
amidohydrolase superfamily
members. The tree was
generated using the NCBI
Taxonomy Browser [61]
Table 4 Success rates for the steps in the structural genomics pipe-
line as of June 2008
Step Amidohydrolase
superfamily
Enolase
superfamily
Both
superfamilies
Total Fraction
(%)
Total Fraction
(%)
Total Fraction
(%)
In pipeline 279 222 501
Cloned 254 91 206 93 460 92
Expressed 225 88 177 86 402 87
Soluble 167 74 112 63 279 69
Puriﬁed 110 66 67 60 177 63
Crystallized 63 57 44 66 107 60
Unique
structures
20 32 41 93 61 57
All
structures
25 50 75
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123barrel fold, as well as currently unidentiﬁed members of
the amidohydrolase and enolase superfamilies, because the
sequence databases have been growing by approximately
50% since 2005, and also because we concentrated on
selecting only targets from the NYSGXRC genomes in the
target selection process for this project.
Distribution of targets over the amidohydrolase
and enolase superfamilies
For large groups of related sequences, such as the amido-
hydrolase superfamily network-based visualization of their
relationships is helpful in generating hypotheses about how
various enzymes in the superfamily evolved, and on how
closely the subgroups are related to each other. We have
plotted cytoscape networks for the amidohydrolase and
enolase superfamilies, based on clustering by sequence
similarity, and marked previously known structures, and
the ﬁnal targets and the structures from this project
(Fig. 3). For clarity, we circled a few distinct subgroups.
Another network representation with all sub-group
assignments can be found in the supplemental materials.
Many subgroups in the large amidohydrolase super-
family, such as the urease-like subgroup and the uronate
isomerase-like subgroup, are distinctly separated from the
other superfamily members. This separation can most
simply be interpreted as the result of the extreme diver-
gence of these subgroups; thus, they are ‘‘outliers’’ in the
overall context of the superfamily (see below for further
discussion of this subgroup).
Four of the ﬁve divergent amidohydrolase structures
with a considerably smaller number of homologs are sep-
arated from the main amidohydrolase network, even at the
relatively non-stringent E-value cut-off of 10
-10 required
to visualize connections between nodes. Two of them
(2Q01, 2Q6E) belong to the uronate isomerase-like sub-
group. Another two of these structures (2RAG, 3B40) are
clustered together with a number of unclassiﬁed sequences
as well as several membrane dipeptidase-like amidohy-
drolase superfamily members, possibly indicating that
these targets are additional members of the membrane
dipeptidase subgroup. This subgroup membership is also
supported by their annotation as putative dipeptidases in
UniProt.
For the enolase superfamily, we chose to generate a
cytoscape network that represents only four subgroups,
containing the majority of the targets. The targets were
mostly chosen from the mandelate racemase-like subgroup,
because it is the largest subgroup with little previous
structural coverage, and from the more divergent muconate
cycloisomerase subgroup. The cytoscape networks illus-
trate that the targets and the resulting structures are indeed
concentrated in regions of superfamily sequence space that
lacked structural characterization prior to the start of the
project, as desired for our target selection.
Examples of biological impact resulting from new
structures obtained in this study
Amidohydrolase superfamily example: atypical uronate
isomerase Bh0493
The enzymes in the uronate isomerase family are members
of the amidohydrolase superfamily, although they are
extremely diverged from other clusters of the amidohy-
drolase superfamily network (Fig. 3a). Target 9247a (gi
10173106, Bh0493) from Bacillus halodurans was identi-
ﬁed by our structure-based expansion as a putative member
of the amidohydrolase superfamily and has recently been
experimentally conﬁrmed as a uronate isomerase [29]. In
most organisms, both glucuronic acid and galacturonic acid
are ﬁrst isomerized by a single uronate isomerase, followed
by further modiﬁcation by several sugar speciﬁc dehydro-
genases and dehydratases. In B. halodurans, as in several
other organisms, two uronate isomerase genes are found, in
Table 5 Comparison of template-based modeling statistics for the 61 ENSPEC/NYSGXRC structures and all 327 NYSGXRC structures (May
2007)
Amidohydrolase and enolase superfamily
members
All
Average number of sequences with acceptable models 2,681 1,964
Minimum/maximum number of sequences with acceptable models 189/3693 30/6320
Average number of sequences with[50% sequence identity, at least 50% coverage 15 20
Average number of sequences with 30–50% sequence identity, at least 50%
coverage
59 113
Average number of sequences with\30% sequence identity, at least 50% coverage 2,572 1,400
An acceptable model is deﬁned to be based on a signiﬁcant PSI-BLAST E-value (0.0001) or a favorable GA341 model score ([0.7)
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123operons containing dehydrogenase as well as dehydratase
enzymes, consistent with this assignment of activity. We
characterized both uronate isomerase genes, a ‘‘typical’’
uronate isomerase, Bh0705, and Bh0493, an ‘‘outlier’’
relative to other characterized members of this family
(Fig. 4a). Although the results showed that each enzyme
can isomerize both substrates, galacturonate and glucuro-
nate, the Bh0705 uronate isomerase preferentially
isomerizes glucuronic acid (approximately 100 times faster
than galacturonic acid). In contrast, Bh0493 isomerizes
glucuronic acid and galacturonic acid almost equally efﬁ-
ciently. These observations indicate that in B. halodurans,
the ‘‘typical’’ uronate isomerase (Bh0705) has specialized
its catalytic activity to preferentially isomerize glucuronic
acid, perhaps because the isomerization of galacturonic
acid is sufﬁciently achieved by Bh0493.
Fig. 3 a Cytoscape clustering for the amidohydrolase superfamily.
The most homogeneous subgroups have been named. An additional
ﬁgure with full subgroup coloring is available in Supplemental
Materials. Green diamonds Structures determined prior to the start of
the ENSPEC/NYSGXRC project in June 2005. Red triangles
Superfamily members in the target list. Purple squares Five divergent
structures determined by ENSPEC/NYSGXRC. Blue squares All
other structures determined by ENSPEC/NYSGXRC. Ovals indicate
subgroups: red dihydroorotase 3-like; dark blue urease-like; purple
NagA/AgaA-like; light-blue: 2-Pyrone-4,6-dicarboxylate lactonase-
like; pink uronate-isomerase-like; orange PHP-like; delft-blue mem-
brane dipeptidase-like. b Cytoscape clustering for the enolase
superfamily. Subgroup clusters are marked for four subgroups. The
full subgroup assignments can be found in Supplemental Materials.
Green diamonds Structures determined prior to the start of the
ENSPEC/NYSGXRC project in June 2005. Red triangles Superfam-
ily members in the target list. Blue squares All structures determined
by ENSPEC/NYSGXRC. Ovals indicate subgroups: pink mannonate
dehydratase-like; orange mandelate racemase-like; blue muconate
cycloisomerase-like; green glucarate dehydratase-like
b
Fig. 4 a Cytoscape network
showing the uronate isomerase
family. The E-value threshold
for displaying edges is 10
-10.
The large cluster represents the
‘‘typical’’ uronate isomerases;
sequences in this cluster are
more similar to other members
of the amidohydrolase
superfamily than is Bh0493.
Bh0705 is shown in purple and
the structurally characterized
enzyme from Thermotoga
maritima is shown in red. On
the right, the outlier uronate
isomerase, Bh0493, is shown in
purple along with a small
number of sequences of
unknown function. b Ribbon
diagram [62] of a superposition
of the trimeric structures of
Bh0493 (2Q6E, blue) and a
uronate isomerase from
Thermotoga maritima (1J5S,
red). The detailed box shows the
active site residues of chain A
including a Zn
2? ion for 2Q6E
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between Bh0493 and the ‘‘typical’’ uronate isomerases
(and between uronate isomerases and other members of
the amidohydrolase superfamily), and in the absence of a
structure of Bh0705, we compared the structure of
Bh0493 (PDB codes 2Q08 and 2Q6E) to another ‘‘typi-
cal’’ uronate isomerase from Thermotoga maritima (PDB
code 1J5S). As shown in Fig. 4b, the functionally
important residues Arg170, Arg357 and His49, are con-
served and cluster together within the enzyme active site
both in the T. maritima enzyme and Bh0493. However, an
additional metal-coordinating histidine that is usually
found at the end of b-strand ﬁve in ‘‘typical’’ uronate
isomerases (H290 in the 1J5S) is missing in Bh0493,
which has a Met (M258) in that position. The Zn
2? ion is
coordinated by two histidine residues (His28 and His26)
plus Asp355. Guided by these structures, further bio-
chemical and computational studies to examine the
differences between these two types of uronate isome-
rases, and how they may be related to their different
speciﬁcities, are currently in progress.
Enolase superfamily example: mandelate racemase
subgroup
The SFLD currently describes 17 different families in the
enolase superfamily, each performing a different overall
reaction associated with different substrates and products.
For the approximately 50% of the superfamily sequences
whose functions are yet unknown, we estimate that roughly
15–20 novel functions (i.e. new families) will be identiﬁed.
Across the superfamily, the sequences whose functions
are not yet identiﬁed can be clustered into three primary
subgroups and several smaller ones based on sequence
and structural differences, including differences in the
constellations of active site residues involved in binding
speciﬁcity and catalysis [10]. In the mandelate racemase
subgroup, most of the enzymes with characterized reac-
tions are dehydratases acting on acid sugars, with the
‘‘outlier’’ enzyme being mandelate racemase itself. All
structurally characterized members of the subgroup can be
distinguished by a His-Asp dyad at the ends of b-strands
six and seven that is associated with proton abstraction of
substrates in the R-conﬁguration [59]. Mandelate racemase
and several acid sugar dehydratases that were previously
structurally and functionally characterized also have a
conserved Lys-X-Lys motif on b-strand two, with the
second Lys in this motif involved in proton abstraction of
substrates in the S-conﬁguration [42]. Within this sub-
group, we also observe divergence in this motif among
several members of both known [32] and unknown
function.
Three members of the mandelate racemase subgroup
whose structures were determined by NYSGXRC, 2GL5
and 2O56 from Salmonella typhimurium and 2OX4 from
Zymomonas mobilis, were found to have a Lys-Val-Asp
sequence motif at this position, possibly indicating a
different catalytic mechanism or yet other novel func-
tion(s). The three structures align within 50% sequence
identity to each other. The next closest structures (30%
sequence identity) are also members of the mandelate
racemase subgroup: 2POZ from Mesorhizobium loti and
2POD from Burkholderia pseudomallei have Lys-Phe-Tyr
and Lys-Ile-Trp motifs at this position, respectively,
providing further evidence for divergent catalytic func-
tion(s). Their structures reveal details of differences
relative to that of well-characterized subgroup members
containing a ‘‘canonical’’ Lys-X-Lys motif, providing
information expected to be useful in identifying their
functions. Figure 5 shows superpositions of mandelate
racemase with 2GL5 and 2POD, illustrating the differ-
ences in this motif. Guided by these new structures, these
enzymes are now being further analyzed computationally
and experimentally.
Conclusion
The Enzyme Speciﬁcity Consortium and the New York
SGX Research Center for Structural Genomics made sig-
niﬁcant progress towards characterizing the structures and
functions in the amidohydrolase and enolase superfamilies.
New members of the amidohydrolase superfamily have
been identiﬁed through a combination of sequence- and
structure-based expansions of the pool of known super-
family members. The structure-based expansion was
particularly successful in identifying previously unrecog-
nized superfamily members. The 63 crystallographic
structures from the structural genomics pipeline increased
the fraction of the sequences in these two superfamilies that
can be modeled based on at least 30% sequence identity
from 45% to 73%.
As an annotation tool for the targets in the two
superfamilies, template-based modeling of all sequen-
ces that had detectable homology to a known structure
in the amidohydrolase or enolase superfamily allowed
us to suggest previously un-annotated amidohydrolase
sequences, several of which were subsequently veriﬁed
by experiment, as shown for Bh0493 in this paper.
This demonstrates the power of combining sequence-
and structure-based approaches for the structural
genomics of two large and diverse enzyme
superfamilies.
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in 2GL5. b Superposition of
2POD (green) with 1MDR also
shows conservation of all of
listed residues, except for the
second Lys in the Lys-X-Lys
motif that is replaced in 2POD
by W176
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